-+ 0.00%
-+ 0.00%
-+ 0.00%

Odyssey Therapeutics Q3 EPS $(1.10) Misses $(1.08) Estimate

Benzinga·11/04/2026 12:17:32
Listen to the news
Odyssey Therapeutics (NASDAQ:ODTX) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(1.08) by 1.85 percent.